You have 9 free searches left this month | for more free features.

Primary refractory

Showing 9926 - 9950 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prenatal Alcohol Exposure Trial in Lille (Facial Emotion Test)

Active, not recruiting
  • Prenatal Alcohol Exposure
  • Facial Emotion Test
  • Lille, France
  • +1 more
Sep 30, 2022

Fibromyalgia, Primary Trial (Psilocybin, Dextromethorphan)

Not yet recruiting
  • Fibromyalgia, Primary
  • (no location specified)
Sep 30, 2022

Age on Sperm Recovery of Microdissection Testicular Sperm

Completed
  • Non-obstructive Azoospermia
    • Beijing, Beijing, China
      Peking University Third Hospital
    Jul 21, 2023

    Parkinson Disease Trial in Korea, Republic of (Safinamide Mesilate)

    Recruiting
    • Parkinson Disease
    • Safinamide Mesilate
    • Busan, Korea, Republic of
    • +19 more
    Apr 25, 2022

    Enterostomy Trial in Austria, Germany, Netherlands (mucous fistula refeeding)

    Recruiting
    • Enterostomy
    • mucous fistula refeeding
    • Graz, Austria
    • +14 more
    Mar 16, 2022

    Pouchitis, Ulcerative Colitis Trial in Helsinki (Fecal microbiota transplantation, Placebo)

    Completed
    • Pouchitis
    • Ulcerative Colitis
    • Fecal microbiota transplantation
    • Placebo
    • Helsinki, Finland
      Helsinki University Central Hospital
    Apr 1, 2021

    Points Score System Predicting 30-day Survival

    Recruiting
    • Metastatic Cancer
    • Point score prediction tool for 30-day survival
    • Avon, Indiana
    • +4 more
    Aug 2, 2022

    Cirrhosis, Ascites, Hepatorenal Syndrome Trial in United States (OCE-205, Placebo)

    Recruiting
    • Cirrhosis
    • +3 more
    • San Francisco, California
    • +6 more
    Aug 3, 2022

    COVID-19 Pneumonia, Sars-CoV-2 Infection Trial in Italy (Reparixin, Placebo)

    Recruiting
    • COVID-19 Pneumonia
    • Sars-CoV-2 Infection
    • Ferrara, Italy
    • +9 more
    Aug 3, 2022

    QIST Collaborative - Arthroplasty Research Cohort (ARC) Study

    Not yet recruiting
    • Hip Arthritis
    • Knee Arthritis
    • Hip/Knee Replacement
    • (no location specified)
    Apr 10, 2023

    Multiple Myeloma Trial in Shanghai (Anti-BCMA CAR-T cells, Fludarabine, Cyclophosphamide)

    Recruiting
    • Multiple Myeloma
    • Anti-BCMA CAR-T cells
    • +3 more
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Aug 29, 2021

    Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety

    Completed
    • Sjogren's Syndrome
    • +5 more
    • FACT-F questionnaire
    • +6 more
    • Yıldırım, Bursa, Turkey
      Koray Ayar
    Nov 29, 2021

    Premature Ventricular Contractions, Ventricular Dysfunction, Left Trial (Experimental group, Control group)

    Not yet recruiting
    • Premature Ventricular Contractions
    • Ventricular Dysfunction, Left
    • Experimental group
    • Control group
    • (no location specified)
    Mar 27, 2023

    Muscular Atrophy, Spinal Trial (No Intervention)

    Not yet recruiting
    • Muscular Atrophy, Spinal
    • No Intervention
    • (no location specified)
    Mar 16, 2023

    Thoracoabdominal Aortic Aneurysm Trial in Nashville (Thoracoabdominal Aortic Aneurysm Repair)

    Terminated
    • Thoracoabdominal Aortic Aneurysm
    • Thoracoabdominal Aortic Aneurysm Repair
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Feb 8, 2022

    Response To Dengue Exposure Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rDENdelta30/31-7164)

    Not yet recruiting
    • Response To Dengue Exposure
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Pelvic Pain Syndrome Trial in Kafr Ash Shaykh (Percutaneous Posterior Tibial Nerve Stimulation, Placebo Percutaneous Posterior

    Active, not recruiting
    • Pelvic Pain Syndrome
    • Percutaneous Posterior Tibial Nerve Stimulation
    • +2 more
    • Kafr Ash Shaykh, Egypt
      Kafrelshaikh University
    Oct 8, 2023

    Covid19, Vaccine Refusal Trial in Boston (Messaging informed by construal level theory, Usual Care)

    Active, not recruiting
    • Covid19
    • Vaccine Refusal
    • Messaging informed by construal level theory
    • Usual Care
    • Boston, Massachusetts
      Mass General Brigham
    Jun 2, 2022

    Neuromuscular Blockade Trial in Genève, Lugano, Sion (Magnesium Sulfate)

    Not yet recruiting
    • Neuromuscular Blockade
    • Magnesium Sulfate
    • Genève, Geneva, Switzerland
    • +2 more
    Jul 13, 2022

    Soft Tissue Sarcoma Trial in Charleston (Hypofractionated Radiation Therapy)

    Not yet recruiting
    • Soft Tissue Sarcoma
    • Hypofractionated Radiation Therapy
    • Charleston, South Carolina
      Medical University of South Carolina
    Mar 8, 2023

    Cognitive Decline, COVID-19, SARS CoV 2 Infection Trial in Hangzhou (hyperbaric oxygen therapy, conventional oxygen therapy)

    Not yet recruiting
    • Cognitive Decline
    • +2 more
    • hyperbaric oxygen therapy
    • conventional oxygen therapy
    • Hangzhou, Zhejiang, China
      First Affiliated Hospital of Zhejiang Chinese Medical University
    Feb 6, 2023

    Breast Cancer, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy Trial in Fuzhou (carbon dye)

    Recruiting
    • Breast Cancer
    • +2 more
    • carbon dye
    • Fuzhou, Fujian, China
      Study Officials
    Aug 22, 2022

    New Echocardiographic Indicators in Treatment of Primary

    Not yet recruiting
    • Multiple Myeloma
    • Chemotherapy and/or autologous hematopoietic stem cell transplantation
    • (no location specified)
    Sep 18, 2023

    Acquired Hyperinsulinemic Hypoglycemia Trial in Palo Alto (Avexitide)

    Recruiting
    • Acquired Hyperinsulinemic Hypoglycemia
    • Palo Alto, California
      Clinical and Translational Research Unit
    Mar 31, 2022

    NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • MK-2870
    • +2 more
    • (no location specified)
    Oct 3, 2023